Initial results of a phase II study of oxaliplatin (OX), capecitabine (CAP), bevacizumab (BV), and cetuximab (CET) in the treatment of metastatic colorectal cancer (mCRC)

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Bendell, JC; Uronis, HE; Morse, MA; Blobe, G; Aklilu, M; Nixon, A; Niedzweicki, D; Honeycutt, W; Howard, L; Hurwitz, H

Published Date

  • May 20, 2008

Published In

Volume / Issue

  • 26 / 15_suppl

Start / End Page

  • 4063 - 4063

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2008.26.15_suppl.4063

Language

  • en